KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Non Operating Income (2016 - 2025)

Johnson & Johnson's Non Operating Income history spans 17 years, with the latest figure at -$483.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 400.0% year-over-year to -$483.0 million; the TTM value through Dec 2025 reached $7.2 billion, up 253.58%, while the annual FY2025 figure was $7.2 billion, 253.58% up from the prior year.
  • Non Operating Income for Q4 2025 was -$483.0 million at Johnson & Johnson, down from $478.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $7.3 billion in Q1 2025 and bottomed at -$6.9 billion in Q2 2023.
  • The 5-year median for Non Operating Income is -$273.0 million (2022), against an average of -$424.4 million.
  • The largest YoY upside for Non Operating Income was 2133.33% in 2021 against a maximum downside of 14612.5% in 2021.
  • A 5-year view of Non Operating Income shows it stood at -$1.8 billion in 2021, then skyrocketed by 87.78% to -$226.0 million in 2022, then soared by 286.28% to $421.0 million in 2023, then crashed by 61.76% to $161.0 million in 2024, then plummeted by 400.0% to -$483.0 million in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Non Operating Income are -$483.0 million (Q4 2025), $478.0 million (Q3 2025), and -$107.0 million (Q2 2025).